Hippocampal Sclerosis Detection with NeuroQuant Compared with Neuroradiologists

Area of Science:

• Neurology
• Radiology
• Medical Imaging Analysis

Background:

• Automated quantitative volumetric analysis of MR imaging is increasingly utilized in clinical practice.
• Hippocampal sclerosis is a key indicator for temporal lobe epilepsy surgery.
• Expert visual assessment by neuroradiologists is the current standard for identifying hippocampal sclerosis.

Purpose of the Study:

• To compare the diagnostic accuracy of FDA-approved NeuroQuant software with expert neuroradiologist visual analysis in detecting hippocampal sclerosis.
• To evaluate NeuroQuant's utility in presurgical evaluation for temporal lobe epilepsy.

Main Methods:

• Retrospective review of 144 adult patients undergoing presurgical evaluation for temporal lobe epilepsy.
• Pathology served as the reference standard for hippocampal sclerosis.
• Comparison of sensitivities, specificities, positive predictive values, and negative predictive values between NeuroQuant and visual MR imaging analysis.

Main Results:

• NeuroQuant demonstrated similar specificity (90.4% vs 91.6%) but significantly lower sensitivity (69.0% vs 93.0%) compared to expert visual analysis.
• Positive predictive values were comparable (84.0% vs 89.1%), while negative predictive values differed substantially (79.8% vs 95.0%).

Conclusions:

• Expert visual MR imaging analysis offers higher sensitivity for detecting hippocampal sclerosis, likely due to its ability to assess T2 signal and architecture.
• NeuroQuant is a valuable tool for identifying potential candidates when results are positive, especially in centers lacking epilepsy-specialized neuroradiologists.
• Negative NeuroQuant results warrant further evaluation to rule out false negatives and ensure accurate patient selection for epilepsy surgery.